This inventor holds 1 USPTO granted patent. Top assignee: Baker Norton Pharmaceuticals, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations in Ovarian Cancer Treatment by Karl Mettinger
Introduction
Karl Mettinger is an accomplished inventor based in Miami Shores, FL (US). He has made significant contributions to the field of oncology, particularly in the treatment of ovarian cancer. His innovative approaches have the potential to improve patient outcomes and reduce side effects associated with traditional treatments.
Latest Patents
Karl Mettinger holds a patent for "Methods and compositions for treatment of ovarian cancer." This patent outlines compositions and methods that are effective in treating ovarian cancer. The compositions can be administered through long-term infusion schedules of at least 72 hours, allowing for dosages that are safe and manageable in terms of side effects. Notably, it has been demonstrated that longer infusion periods, such as 96 hours, result in substantially lower neuropathy and other side effects compared to shorter-term infusions. He has 1 patent related to this groundbreaking work.
Career Highlights
Karl Mettinger is associated with Baker Norton Pharmaceuticals, Inc., where he continues to develop innovative treatments for cancer. His work focuses on improving the efficacy and safety of cancer therapies, particularly for patients whose tumors have progressed or failed to respond to prior treatments.
Conclusion
Karl Mettinger's contributions to the field of ovarian cancer treatment exemplify the importance of innovation in medicine. His patented methods and compositions offer hope for improved patient care and outcomes in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile